Evidence map›Paper›PMID 31636701›Full record

ArticleJournal of biological engineering2019

De Novo Isolation & Affinity Maturation of yeast-displayed Virion-binding human fibronectin domains by flow cytometric screening against Virions.

Pete Heinzelman, Alyssa Low, Rudo Simeon, Gus A Wright, Zhilei Chen

Open access · goldAbstract read
In one paragraph

Article in Journal of biological engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pete Heinzelman1Department of Microbial Pathogenesis & Immunology, Texas A&M University, College Station, Texas 77843 USA.
Alyssa Low1Department of Microbial Pathogenesis & Immunology, Texas A&M University, College Station, Texas 77843 USA.
Rudo Simeon1Department of Microbial Pathogenesis & Immunology, Texas A&M University, College Station, Texas 77843 USA.
Gus A Wright2Department of Veterinary Pathobiology, Texas A&M University, College Station, Texas 77843 USA.
Zhilei Chen1Department of Microbial Pathogenesis & Immunology, Texas A&M University, College Station, Texas 77843 USA.ORCID 0000-0002-0244-3556
Texas A&M Health Science Center · USTexas A&M University · US

Funding

Artificial Ecology Sink as prophylaxis against viral infectionDP2AI136600 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI CHEN, ZHILEI · 2017 to 2017
$2.2M
CYTOBITS - A HIGH-THROUGHPUT SCREENING INNOVATION ENABLING ENGINEERING OF HUMAN FIBRONECTIN DOMAINS FOR ENHANCED BRAIN DELIVERY OF ALZHEIMER'S DISEASE THERAPEUTICSR21AG056574 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI HEINZELMAN, PETER J · 2017 to 2018
$428k
NIAID NIH HHS DP2 AI136600NIA NIH HHS R21 AG056574
6 · The paper itself

Abstract

backgroundThe promise of biopharmaceuticals comprising one or more binding domains motivates the development of novel methods for de novo isolation and affinity maturation of virion-binding domains. Identifying avenues for overcoming the challenges associated with using virions as screening reagents is paramount given the difficulties associated with obtaining high-purity virus-associated proteins that retain the conformation exhibited on the virion surface.

resultsFluorescence activated cell sorting (FACS) of 1.5 × 10

conclusionsFACS of a yeast-displayed binding domain library is an efficient method for de novo isolation of virion-binding domains. Affinities of isolated virion-binding clones are readily enhanced via FACS screening of mutant progeny libraries. Given that most binding domains are compatible with yeast display, the approach taken in this work may be broadly utilized for generating virion-binding domains against many different viruses for use in passive immunotherapy and the prevention of viral infection.

Indexed as

AIDSantibody engineeringdirected evolutionfibronectinFlow cytometryHuman Immunodeficiency Virusphage displayprotein engineeringyeast displayZika virus

Identifiers

PMID31636701
PMCPMC6796422
OpenAlexW2980827803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.